A major advance in cancer study is occurring with the use of nanobodies to restore dysfunctional p53. This essential tumor protector protein is frequently disabled in various types of cancer, resulting uncontrolled https://bookmarkcolumn.com/story21734871/mini-antibodies-reactivate-p53-the-new-approach-for-cancer-management